Paper
4 March 2019 Alzheimer’s disease: label-free fluorescence shows increases in indoleamine 2,3-dioxygenase (IDO) or tryptophan 2,3-dioxygenase (TDO) activity in affected areas of the brain
Author Affiliations +
Abstract
Abnormal tryptophan metabolism is a major factor in Alzheimer’s disease. Thus, understanding the role of indoleamine 2,3-dioxygenase (IDO) and tryptophan 2,3-dioxygenase (TDO), enzymes that causes increased tryptophan metabolism down the kynurenine pathway, is crucial. Tissue samples from the hippocampus, Brodmann’s area 9 (BA 9) and Brodmann’s area 17 (BA 17) from Alzheimer’s patients, from patients with psychosis and from age-matched, normal controls (total of 47 samples) were studied. An update on the optical properties of Alzheimer’s tissues, utilizing tryptophan/kynurenine ratios, is reported. Ratios of tryptophan/kynurenine were decreased in the hippocampus and BA 9 in patients with Alzheimer’s, consistent with increased neuroinflammation and IDO and/or TDO activity in these areas.
© (2019) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Laura A. Sordillo, Lin Zhang, Peter P. Sordillo, and Robert R. Alfano "Alzheimer’s disease: label-free fluorescence shows increases in indoleamine 2,3-dioxygenase (IDO) or tryptophan 2,3-dioxygenase (TDO) activity in affected areas of the brain", Proc. SPIE 10873, Optical Biopsy XVII: Toward Real-Time Spectroscopic Imaging and Diagnosis, 108731C (4 March 2019); https://doi.org/10.1117/12.2513384
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Alzheimer's disease

Brain

Tissues

Luminescence

Optical properties

Cancer

Oncology

Back to Top